Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
LASA
Do Not Crush
Therapeutic Interchange
Non-Formulary
REMS
High Cost Drugs
Renal Dosing
Hazardous Drugs
Restricted
Questions & Suggestions (Position 3)
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
LASA
Do Not Crush
Therapeutic Interchange
Non-Formulary
REMS
High Cost Drugs
Renal Dosing
Hazardous Drugs
Restricted
Questions & Suggestions (Position 3)
Webpage Links
Search results for:
buprenorphine-naloxone
buprenorphine-naloxone
Drug Name
Form
Strength
Non-Formulary
Restricted
Renal Dosing
REMS
Therapeutic Interchange
Notes
Buprenorphine/Naloxone (Suboxone) film
FILM, BUCCAL
Buprenorphine-Naloxone
FILM, SUBLINGUAL
12 mg-3 mg
Suboxone
FILM, SUBLINGUAL
12 mg-3 mg
Buprenorphine-Naloxone
TABLET, SUBLINGUAL
8 mg-2 mg
VIEW MORE
Opioid Partial Agonists
CLASS
280812
Additional Information:
Drug Name
Common Side Effects
buprenorphine-naloxone
nausea, vomiting
dizziness, headache
difficulty sleeping (insomnia)
Last updated:
Oct. 22, 2024
Black Box Warning:
Implant: Implant Migration, Protrusion, Expulsion, and Nerve Damage Associated with Insertin and Removal
REMS:
View FDA REMS Info
REMS:
FDA Med Guide Comprehensive List
REMS:
BTOD (buprenorphine containing transmucosal) REMS for Pharmacists
UpToDate
Recent Citations via Medline (PubMed)
FDA Daily Med Package Inserts
FDA Approved Drug Products
Drugs.com/Pill Identifier
Rhazdrugs:
buprenorphine-naloxone
buprenorphine-naloxone